Translation. Region: Russian Federal
Source: Government of the Russian Federation – Government of the Russian Federation –
An important disclaimer is at the bottom of this article.
The decision will stimulate businesses developing the production of medicines in the country.
From January 1, 2026, a point system for assessing the level of localization of production in the pharmaceutical industry will come into effect in Russia. The decree on this was signed by Prime Minister Mikhail Mishustin.
The main goal of introducing a new system for assessing the origin of goods is to expand the range of pharmaceuticals produced in Russia, as well as to create additional incentives for the development of the industry and the development of promising technologies for the production of medicines.
Starting from the new year, points will be awarded for establishing the production of medicines and pharmaceutical substances in the country. Products will be considered Russian upon collecting a certain number of points. The decision on this will be made by the Ministry of Industry and Trade.
Manufacturers whose products are recognized as Russian will gain access to government support instruments.
The scoring mechanism for confirming the production of industrial products in Russia was launched in 2015 and is currently in effect in many industries.
The document will be published.
Please note: This information is raw content obtained directly from the source of the information. It is an accurate report of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.